Skip to content
DataLookout
Menu

NCT07888556

Exploring Curative Model for Advanced Breast Cancer: a Single-center, Prospective Phase II Clinical Study

StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

3-year PFS rate after treatment discontinuation
Timeframe: 3 years after treatment discontinuation

Secondary (4)

1-year PFS rate after treatment discontinuation
5-year PFS rate after treatment discontinuation
OS
QOL

Arms and interventions

Cohort A

Continue the original anti-tumor treatment regimen for 1 year

Cohort B

Continue the original anti-tumor treatment regimen for 2 years

Cohort C

Continue the original anti-tumor treatment regimen for 3 years

Sites

1 site in 1 country

  • Henan Breast Cancer Center, The Affiliated Cancer Hospital of Zhengzhou UniversityZhengzhou, Henan, China